RecruitingNot ApplicableNCT05933083

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

Sponsor

University of California, San Francisco

Enrollment

516 participants

Start Date

Oct 27, 2023

Study Type

INTERVENTIONAL

Conditions

Heart Transplant Myocardial Infarction Coronary Artery Disease Heart Valve Diseases Heart Failure, Systolic Angina, Stable

Summary

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do not participate in cardiac rehabilitation. Some find it challenging to attend the in-person sessions. This study aims to compare two methods of delivering cardiac rehabilitation: in-person and through telehealth. The investigators want to know if the effects of these two programs are alike and if certain individuals benefit more from one program over the other.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing two types of cardiac rehabilitation — in-person sessions and telehealth (online/remote) sessions — to see which works better for heart patients. Cardiac rehabilitation is a medically supervised exercise and lifestyle program that helps people recover after heart events. **You may be eligible if...** - You are 18 or older - You had a heart attack, heart surgery, coronary procedure, heart valve repair/replacement, heart transplant, or have chronic stable angina or heart failure - Your doctor has referred you to cardiac rehabilitation - You can communicate in English or Spanish - You are willing to be randomly assigned to either in-person or telehealth rehab **You may NOT be eligible if...** - You have unstable heart rhythm problems - You are unable to exercise safely - You do not meet insurance or referral requirements for cardiac rehab Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.